What does JH stand for?

Juvenile Haemochromatosis

Juvenile Haemochromatosis (JH) is a rare genetic disorder characterized by excessive iron accumulation in the body, leading to organ damage. This condition typically manifests in the first two decades of life, distinguishing it from the more common adult-onset haemochromatosis. The excess iron deposits can cause serious complications, including liver cirrhosis, diabetes, and heart failure, making early diagnosis and treatment crucial.

The management of JH involves regular phlebotomy to reduce iron levels and chelation therapy in some cases. Genetic counseling is also recommended for affected families, as the condition is inherited in an autosomal recessive manner. Research into JH is ongoing, with scientists exploring more effective treatments and the potential for gene therapy. The rarity of JH poses challenges for diagnosis and treatment, underscoring the need for increased awareness among healthcare providers.